Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa

This article discusses the high potential of the RTS,S vaccine for malaria in children. Additionally, results show that not only will the vaccine likely lead to positive health outcomes, but it is expected to do so in a cost-effective manner.

Author: , , , , ,
Publication date: January 2017
Source: Vaccine

The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models

Adding RTS,S to existing control programs, assuming continuation of current levels of malaria exposure and of health system performance, will potentially avert 100–580 malaria deaths and 45,000 to 80,000 clinical episodes per 100,000 fully vaccinated children over an initial 10-year phase.

Author: , , , ,
Publication date: July 2015
Source: Bio Med Central